ARCT Q2 2021 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena

ARCTArcturus Therapeutics Holdings Inc.

$210M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-13.8% YoY

Gross Profit

-$44M-2182.8% margin

Operating Income

-$54M-2684.7% margin

Net Income

-$55M-2727.7% margin

EPS (Diluted)

$-2.07

QoQ Revenue Growth

-5.9%

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$33M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$449M

Total Liabilities

$143M

Stockholders' Equity

$306M

Cash & Equivalents

$434M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	-13.8%
Gross Profit	-$44M	$2M	-1981.1%
Operating Income	-$54M	-$10M	-435.0%
Net Income	-$55M	-$10M	-431.8%